Harnessing the 14-3-3 protein–protein interaction network
Paulo Pitasse-Santos,
No information about this author
Isaac Hewitt-Richards,
No information about this author
Malsha D. Abeywickrama Wijewardana Sooriyaarachchi
No information about this author
et al.
Current Opinion in Structural Biology,
Journal Year:
2024,
Volume and Issue:
86, P. 102822 - 102822
Published: April 28, 2024
Protein–protein
interactions
(PPIs)
play
a
critical
role
in
cellular
signaling
and
represent
interesting
targets
for
therapeutic
intervention.
14-3-3
proteins
integrate
many
via
PPIs
are
frequently
implicated
disease,
making
them
intriguing
drug
targets.
Here,
we
review
the
recent
advances
field.
It
will
discuss
roles
within
cell,
elucidation
of
their
expansive
interactome,
complex
mechanisms
that
underpin
function.
In
addition,
significant
development
molecular
glues
target
PPIs.
particular,
it
focus
on
novel
discovery
methodologies
have
delivered
selective,
potent,
drug-like
molecules
could
open
new
avenues
precision
tools
medicines.
Language: Английский
Rapid flow-based synthesis of post-translationally modified peptides and proteins: a case study on MYC's transactivation domain
Chemical Science,
Journal Year:
2024,
Volume and Issue:
15(23), P. 8756 - 8765
Published: Jan. 1, 2024
Automated
flow
peptide
synthesis
(AFPS)
gives
access
to
peptides
and
proteins
with
post-translational
modifications
(PTMs)
enables
investigation
of
PTM-mediated
regulation,
was
used
study
the
PTM-dependence
MYC:Bin1
interaction.
Language: Английский
Research advancements in molecular glues derived from natural product scaffolds: Chemistry, targets, and molecular mechanisms
Lina Yin,
No information about this author
Tingting Niu,
No information about this author
Ling Li
No information about this author
et al.
Chinese Herbal Medicines,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 1, 2025
The
mechanism
of
action
traditional
Chinese
medicine
(TCM)
remains
unclear.
Historically,
research
on
TCM
has
mainly
focused
exploring
the
mechanisms
active
components
acting
single
targets.
However,
it
is
insufficient
to
explain
complex
by
which
these
in
treat
diseases.
In
recent
years,
emergence
molecular
glues
(MGs)
theory
provided
new
strategies
address
this
issue.
MGs
are
small
molecules
that
can
promote
interactions
between
proteins
at
their
interface.
characteristic
establish
connections
diverse
protein
structures,
thereby
enabling
a
chemically-mediated
proximity
effect
triggers
wide
spectrum
biological
functions.
Natural
products
result
billions
years
evolutionary
processes
natural
environment.
Thus,
extensive
structural
diversity
renders
them
rich
source
MGs,
including
polyketides,
terpenoids,
steroids,
lignans,
organic
acids,
alkaloids
and
other
classes.
Currently,
several
well-known
immunosuppressants
cyclosporin
A
(CsA)
tacrolimus
(FK506),
as
well
anticancer
agent
taxol,
have
been
incorporated
into
clinical
practice.
Meanwhile,
advancement
technologies
propelling
discovery
novel
from
products.
we
primarily
summarize
growing
variety
origins
reported
categorize
based
chemical
types.
Moreover,
main
sources
promises
provide
perspective
for
elucidation
behind
efficiency
TCM.
summary,
review
aims
insights
could
potentially
influence
modern
drug
development.
Language: Английский
Traversing the drug discovery landscape using native mass spectrometry
Current Opinion in Structural Biology,
Journal Year:
2025,
Volume and Issue:
91, P. 102993 - 102993
Published: Feb. 1, 2025
Language: Английский
Recent Developments in 14–3–3 Stabilizers for Regulating Protein–Protein Interactions: An Update
Yucheng Tian,
No information about this author
Lan Li,
No information about this author
Liuyi Wu
No information about this author
et al.
Journal of Medicinal Chemistry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 4, 2025
14–3–3
proteins
play
a
crucial
role
in
the
regulation
of
protein–protein
interactions,
impacting
various
cellular
processes
and
disease
mechanisms.
Recent
advancements
have
led
to
development
stabilizers
that
enhance
binding
clients,
presenting
promising
therapeutic
potentials.
This
perspective
provides
an
updated
overview
latest
developments
field
stabilizers,
with
focus
on
their
design,
synthesis,
biological
evaluation.
We
discuss
structural
basis
for
interaction
between
ligands,
highlighting
key
modifications
affinity
selectivity.
Additionally,
we
explore
applications
across
major
areas
such
as
cancer,
metabolic
disorders,
neurodegenerative
diseases.
By
summarizing
recent
research
findings
technological
advancements,
this
aims
shed
light
current
state
stabilizer
outline
future
directions
optimizing
these
compounds
effective
agents.
Language: Английский